Details of the Drug
General Information of Drug (ID: DMFT3J2)
Drug Name |
Decyl-phosphonic acid
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Decylphosphonic acid; 6874-60-8; Decanephosphonic acid; Phosphonic acid, decyl-; 1-Decanephosphonic acid; n-Decylphosphonic acid; 1-DECYLPHOSPHONIC ACID; Phosphonic acid, P-decyl-; EINECS 229-975-2; NSC 407850; BRN 1771572; AI3-23065; CHEMBL188083; DZQISOJKASMITI-UHFFFAOYSA-N; C10H23O3P; DecylphosphonicAcid; 1-decanephosphonicacid; n-Decanephosphonic acid; ACMC-1CUHV; Phosphonic acid,P-decyl-; Decylphosphonic acid, 97%; AC1Q6RQ2; 10; 4-04-00-03564 (Beilstein Handbook Reference); SCHEMBL110008
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 222.26 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 2.9 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 9 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||